| COVID-19 and diabetes mellitus: how one pandemic worsens the other WS Azar, R Njeim, AH Fares, NS Azar, ST Azar, M El Sayed, AA Eid Reviews in Endocrine and Metabolic Disorders 21, 451-463, 2020 | 112 | 2020 |
| NETosis contributes to the pathogenesis of diabetes and its complications R Njeim, WS Azar, AH Fares, ST Azar, HK Kassouf, AA Eid Journal of molecular endocrinology 65 (4), R65-R76, 2020 | 77 | 2020 |
| DeepLensNet: deep learning automated diagnosis and quantitative classification of cataract type and severity TDL Keenan, Q Chen, E Agrón, YC Tham, JHL Goh, X Lei, YP Ng, Y Liu, ... Ophthalmology 129 (5), 571-584, 2022 | 36 | 2022 |
| VEGF-A: a novel mechanistic link between CYP2C-derived EETs and Nox4 in diabetic kidney disease R Njeim, K Braych, HE Ghadieh, NS Azar, WS Azar, B Dia, A Leone, ... Diabetes 72 (7), 947-957, 2023 | 5 | 2023 |
| Translational aspects of the mammalian target of rapamycin complexes in diabetic nephropathy A Abou Daher, S Alkhansa, WS Azar, R Rafeh, HE Ghadieh, AA Eid Antioxidants & Redox Signaling 37 (10-12), 802-819, 2022 | 5 | 2022 |
| SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism B Dia, S Alkhansa, R Njeim, S Al Moussawi, T Farhat, A Haddad, ... Pharmaceutics 15 (3), 965, 2023 | 2 | 2023 |
| Urinary 20-HETE: a prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease P Houeiss, R Njeim, H Tamim, AF Hamdy, TS Azar, WS Azar, ... Journal of Advanced Research 44, 109-117, 2023 | 1 | 2023 |
| MP70-02 DOES PRE-PROSTATECTOMY MAGNETIC RESONANCE IMAGING REDUCE RACIAL DISPARITIES IN ONCOLOGIC OUTCOMES FOR AFRICAN AMERICAN PATIENTS: A PROPENSITY SCORE-MATCHED ANALYSIS KC Schuppe, C Koller, S Parikh, C Hesswani, WS Azar, S Azari, ... Journal of Urology 211 (5S), e1128, 2024 | | 2024 |
| PD33-06 RENAL SURGERY FOLLOWING HIF2ALPHA; ANTAGONIST THERAPY: GROWTH KINETICS AND SURGICAL OUTCOMES D Nethala, J Hyman, N Rathi, J Hsueh, C Hesswani, C Koller, ... Journal of Urology 211 (5S), e711, 2024 | | 2024 |
| MP18-09 MORE THAN MEETS THE EYE: EVALUATING THE EFFECT OF NOVEL NEOADJUVANT ANDROGEN SIGNALING INHIBITION ON PROSTATE MULTIPARAMETRIC MRI CR Koller, SH Parikh, KC Schuppe, C Hesswani, WS Azar, ... Journal of Urology 211 (5S), e304, 2024 | | 2024 |
| MP18-15 THE IMPACT OF MAGNETIC RESONANCE IMAGING-DETECTED ZONAL LOCATION ON PROSTATE CANCER RECURRENCE: IMPLICATIONS FOR PREOPERATIVE RISK STRATIFICATION KC Schuppe, AP Kenigsberg, WS Azar, C Hesswani, SH Parikh, C Koller, ... Journal of Urology 211 (5S), e306, 2024 | | 2024 |
| MP07-18 EVALUATION OF A BIPARAMETRIC MRI AI ALGORITHM FOR THE DETECTION OF PROSTATE CANCER USING SPATIAL ANNOTATIONS ON WHOLEMOUNT PROSTATE PATHOLOGY C Hesswani, EC Yilmaz, SA Harmon, DG Gelikman, CR Koller, SH Parikh, ... The Journal of Urology 211 (5S), e112, 2024 | | 2024 |
| MP30-01 A NEW LOOK: THE PROMISING USE OF 3-DIMENSIONAL QUANTITATIVE TRANSMISSION ULTRASOUND TOMOGRAPHY FOR THE DETECTION OF PROSTATE CANCER AN EX VIVO STUDY SH Parikh, C Hesswani, WS Azar, CR Koller, KC Schuppe, ... The Journal of Urology 211 (5S), e490, 2024 | | 2024 |
| MP31-08 TRANSPERINEAL VERSUS TRANSRECTAL MRI-US FUSION TARGETED PROSTATE BIOPSIES FOR APICAL LESIONS J Siva, N Mendhiratta, A Kenigsberg, KC Schuppe, WS Azar, SH Parikh, ... Journal of Urology 211 (5S), e506, 2024 | | 2024 |
| PD18-03 NATURAL HISTORY OF METASTATIC RENAL CELL CARCINOMA (RCC) ASSOCIATED WITH HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA (HLRCC) D Nethala, N Rathi, J Hyman, J Hsueh, C Hesswani, C Koller, ... Journal of Urology 211 (5S), e432, 2024 | | 2024 |
| MP43-06 IS IT TIME TO ABANDON THE TRANSRECTAL PROBE IN PROSTATE BIOPSY? WS Azar, CR Koller, SH Parikh, C Hesswani, KC Schuppe, SS Azari, ... Journal of Urology 211 (5S), e694, 2024 | | 2024 |
| CLINICAL OUTCOMES OF PATIENTS ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER WITH SMALL INDEX LESIONS ON MRI J Siva, N Mendhiratta, W Azar, S Parikh, K Schuppe, AP Kenigsberg, ... Urologic Oncology: Seminars and Original Investigations 42, S15, 2024 | | 2024 |
| IMPACT OF PI-RADS 5 LESIONS ON ACTIVE SURVEILLANCE FOR GRADE GROUP 1 S Azari, JB Mason, AP Kenigsberg, C Koller, S Parikh, W Azar, K Schuppe, ... Urologic Oncology: Seminars and Original Investigations 42, S95, 2024 | | 2024 |
| FOCAL THERAPY ELIGIBILITY: AN EVALUATION OF INITIAL AND CONTINUED CANDIDACY FOR FOCAL THERAPY IN A GRADE GROUP 2 ACTIVE SURVEILLANCE COHORT JB Mason, S Azari, AP Kenigsberg, Z Blake, DR Nemirovsky, C Koller, ... Urologic Oncology: Seminars and Original Investigations 42, S93, 2024 | | 2024 |
| TRANSPERINEAL VERSUS TRANSRECTAL MRI-US FUSION TARGETED PROSTATE BIOPSIES FOR APICAL LESIONS J Siva, N Mendhiratta, AP Kenigsberg, K Schuppe, W Azar, S Parikh, ... Urologic Oncology: Seminars and Original Investigations 42, S15-S16, 2024 | | 2024 |
Assaad A. EIDAssociate Professor - American University of Beirut, Faculty of MedicineVerified email at aub.edu.lb
